Literature DB >> 32111754

Implantation of an Injectable Bone Substitute Material Enables Integration Following the Principles of Guided Bone Regeneration.

Mike Barbeck1,2, Ole Jung3,4, Alireza Houshmand3, Tadas Korzinskas3, Ralf Smeets3, Martin Gosau3, Reiner Schnettler3, Patrick Rider2.   

Abstract

BACKGROUND/AIM: The present study investigates the in vivo tissue reaction and the integration behavior of an injectable bone substitute material (IBS) composed of a water-based gel combined with nano hydroxyapatite particles and biphasic calcium phosphate granules. The results of the IBS were compared to biphasic bone substitute granules (BBSM) of the same chemical composition.
MATERIALS AND METHODS: The subcutaneous implantation model in 40 female 5-week-old CD-1 mice up to 60 days after implantation was used for conduction of the in vivo experiments. Moreover, established histological, histopathological and histomorphometrical methods were applied.
RESULTS: The results showed that the IBS was gradually invaded by cells and complex tissue elements. Thus, the implant bed could be distinguished in two areas, i.e. an outer and inner region. While the outer region started to interact with the peri-implant tissue by evoking multinucleated giant cells and at earlier time points by undergoing a continuous high vascularization, the inner part was free of peri-implant cells for at least 30 days, starting to undergo a similar tissue reaction at a later time point. The bone substitute granules allowed for a fast tissue influx between the interspaces of the granules starting at day 10. While the vessel density did not differ in both groups up to the end of the study, the amount of vascularization was significantly higher over the entire observation period in the BBSM group. Moreover, the amount of biomaterial-associated multinucleated giant cells (BMGCs) was significantly higher in the IBS group in the period of between 15 to 30 days after implantation, while comparable BMGC numbers were found in both groups towards the end of the study.
CONCLUSION: IBS can build a barrier-like structure that is able to control the soft tissue influx into the central regions of the implantation bed, which could not be observed in other bone substitute granules of the same chemical composition. This directed integration behavior is assumed to be in accordance with the concept of Guided Bone Regeneration (GBR). Furthermore, BMGCs can significantly influence the process of angiogenesis within an implant bed of a biomaterial but not the maturity of blood vessels. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Injectable bone substitute (IBS); biphasic bone substitute (BBSM); bone regeneration; guided bone regeneration (GBR); integration; multinucleated giant cells; vascularization

Year:  2020        PMID: 32111754     DOI: 10.21873/invivo.11808

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  9 in total

Review 1.  Specialized Histological and Histomorphometrical Analytical Methods for Biocompatibility Testing of Biomaterials for Maxillofacial Surgery in (Pre-) Clinical Studies.

Authors:  Carolin Lindner; Annica PrÖhl; Ole Jung; Mike Barbeck; Manuel Abels; Tom LÖffler; Milijana Batinic
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

2.  In Vivo Biocompatibility Investigation of an Injectable Calcium Carbonate (Vaterite) as a Bone Substitute including Compositional Analysis via SEM-EDX Technology.

Authors:  Ronald E Unger; Sanja Stojanovic; Laura Besch; Said Alkildani; Romina Schröder; Ole Jung; Caroline Bogram; Oliver Görke; Stevo Najman; Wolfgang Tremel; Mike Barbeck
Journal:  Int J Mol Sci       Date:  2022-01-21       Impact factor: 5.923

3.  In Vivo Analysis of the Biocompatibility and Immune Response of Jellyfish Collagen Scaffolds and its Suitability for Bone Regeneration.

Authors:  Iris Flaig; Milena Radenković; Stevo Najman; Annica Pröhl; Ole Jung; Mike Barbeck
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

4.  Histological and Radiological Features of a Four-Phase Injectable Synthetic Bone Graft in Guided Bone Regeneration: A Case Report.

Authors:  Marija Čandrlić; Željka Perić Kačarević; Zrinka Ivanišević; Matej Tomas; Aleksandar Včev; Dario Faj; Marko Matijević
Journal:  Int J Environ Res Public Health       Date:  2020-12-29       Impact factor: 3.390

5.  The Granule Size Mediates the In Vivo Foreign Body Response and the Integration Behavior of Bone Substitutes.

Authors:  Manuel Abels; Said Alkildani; Annica Pröhl; Xin Xiong; Rumen Krastev; Tadas Korzinskas; Sanja Stojanovic; Ole Jung; Stevo Najman; Mike Barbeck
Journal:  Materials (Basel)       Date:  2021-12-01       Impact factor: 3.623

6.  Biocompatibility Analyses of HF-Passivated Magnesium Screws for Guided Bone Regeneration (GBR).

Authors:  Ole Jung; Bernhard Hesse; Sanja Stojanovic; Christian Seim; Timm Weitkamp; Milijana Batinic; Oliver Goerke; Željka Perić Kačarević; Patrick Rider; Stevo Najman; Mike Barbeck
Journal:  Int J Mol Sci       Date:  2021-11-22       Impact factor: 5.923

7.  Comparison of Injectable Biphasic Calcium Phosphate and a Bovine Xenograft in Socket Preservation: Qualitative and Quantitative Histologic Study in Humans.

Authors:  Marija Čandrlić; Matej Tomas; Matej Karl; Lucija Malešić; Aleksandar Včev; Željka Perić Kačarević; Marko Matijević
Journal:  Int J Mol Sci       Date:  2022-02-25       Impact factor: 5.923

8.  Treatment of benign bone lesions with an injectable biphasic bone substitute.

Authors:  Kevin Döring; Colleen Rentenberger; Alexander Kolb; Janina Patsch; Stephan Puchner; Reinhard Windhager; Catharina Chiari
Journal:  BMC Musculoskelet Disord       Date:  2022-10-08       Impact factor: 2.562

9.  In Vivo Analysis of the Biocompatibility and Bone Healing Capacity of a Novel Bone Grafting Material Combined with Hyaluronic Acid.

Authors:  Annica Pröhl; Milijana Batinic; Said Alkildani; Michael Hahn; Milena Radenkovic; Stevo Najman; Ole Jung; Mike Barbeck
Journal:  Int J Mol Sci       Date:  2021-05-01       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.